Treatment intensification in metastatic castration-sensitive prostate cancer: a real-world study in Alberta, Canada.
To assess the current status of and factors associated with treatment intensification (TI) (with androgen receptor pathway inhibitors [ARPIs] and/or docetaxel) for metastatic castration-sensitive prostate cancer (mCSPC) in Canada. Retrospective …